Meizhou People Hospital

Meizhou, Guangdong 514031

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumor, Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling